Stemming the wave of cervical cancer: Human papillomavirus vaccine introduction in India
Open accessThe claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Cultural and gender norms heavily influenced HPV vaccine intent in Turkey, Latina populations, Senegalese adolescents, and the U.S.
“These dynamics are consistent with findings from Turkey50, Latina populations52, Senegalese adolescents53 and U.S.54 where cultural and gender norms heavily influenced vaccine intent.”
From Barriers to HPV vaccination among adolescent girls in India: A scoping review (2026) · cites this paper as [53]
The paper’s main text (page unavailable) identifies sociocultural barriers to HPV vaccine rollout in low- and middle-income countries. It does not report that cultural and gender norms heavily influenced vaccine intent in Turkey, Latina populations, Senegalese adolescents, or the U.S.; those populations and the claim about intent are unsupported by this source. (LLM, conf=0.82)
Experimental — accuracy not yet measuredSchool-based HPV vaccination programs in Punjab and Sikkim demonstrated high effectiveness.
“At the Institutional level, school-based vaccination programs in India from Punjab and Sikkim demonstrated high effectiveness.”
From Barriers to HPV vaccination among adolescent girls in India: A scoping review (2026) · cites this paper as [55]
In the main text (page unavailable), the paper reports 97.5% and 98.5% vaccination coverage in two Punjab districts, supporting high uptake among girls in the participating schools. It does not report a Sikkim program or measure the effectiveness of these school-based programs beyond coverage. (LLM, conf=0.88)
Experimental — accuracy not yet measuredState-level HPV vaccination programmes in Punjab and Sikkim provide practical models for effective implementation among school-going girls, supported by mandatory school enrolment, integration of health and education departments, comprehensive training, and strong community engagement.
“In India, the state-level HPV vaccination programmes, particularly from Punjab and Sikkim, provide practical models for effective implementation, among the school-going girls55, supported by mandatory school enrolment, integration of health and education departments, comprehensive training, and strong community engagement56.”
From Barriers to HPV vaccination among adolescent girls in India: A scoping review (2026) · cites this paper as [55]
Split into 2 atoms — 0 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 1 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measuredPhysicians in rural and semi-urban India remain under-utilized for HPV vaccination, a challenge echoed in other LMICs.
“However, physicians in rural and semi-urban India remain under-utilized, a challenge echoed in other LMICs49,53.”
From Barriers to HPV vaccination among adolescent girls in India: A scoping review (2026) · cites this paper as [53]
In the paper’s main text (page unavailable), the authors describe sociocultural, health-system, and financial barriers to HPV vaccine rollout in LMICs. The paper does not say that physicians in rural or semi-urban India are under-utilized for vaccination, or that this specific challenge occurs in other LMICs. (LLM, conf=0.79)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
No references could be resolved yet.
Research works printed but not linked: 11
- [3]Sankaranarayanan R Bhatla N Basu P Current global status and impact of human papillomavirus vaccination: Implications for India Indian J Med Res 144 169 180 2016 27934795 PMC5206867
- [6]Jit M Brisson M Portnoy A et al Cost-effectiveness of female human papillomavirus vaccination in 179 countries: A PRIME modelling study Lancet Glob Health 2 e406 e414 2014 25103394
- [7]Gupta S Kerkar RA Dikshit R et al Is human papillomavirus vaccination likely to be a useful strategy in India? South Asian J Cancer 2 193 197 2013 24455622 PMC3889025
- [8]Sachdeva S Sachdeva R Human papillomavirus vaccination: Review and roll out plan in Delhi http://www.cjhr.org/text.asp?2016/3/4/252/190584
- [9]Lamontagne DS Sherris JD Addressing questions about the HPV vaccine project in India Lancet Oncol 14 e492 2013 24176568
- [10]Larson HJ Brocard P Garnett G The India HPV-vaccine suspension Lancet 376 572 573 2010 20728739
- [11]WHO Human papillomavirus vaccines: WHO position paper, October 2014-recommendations Vaccine 33 4383 4384 2015 25510390
- [14]Gyawali B Iddawela M Bevacizumab in advanced cervical cancer: Issues and challenges for low- and middle-income countries J Glob Oncol 3 93 97 2016 28717748 PMC5493276
- [15]Wigle J Coast E Watson-Jones D Human papillomavirus (HPV) vaccine implementation in low and middle-income countries (LMICs): Health system experiences and prospects Vaccine 31 3811 3817 2013 23777956 PMC3763375
- [16]Biellik R Levin C Mugisha E et al Health systems and immunization financing for human papillomavirus vaccine introduction in low-resource settings Vaccine 27 6203 6209 2009 19698808
- [17]Andrus JK Sherris J Fitzsimmons JW et al Introduction of human papillomavirus vaccines into developing countries: International strategies for funding and procurement Vaccine 26 K87 K92 2008 suppl 10 18847561
Cited by
Sorted by citations
Current status of human papillomavirus vaccination in India's cervical cancer prevention efforts
Sankaranarayanan, R., Basu, P., Kaur, P., Bhaskar, R., Singh, G. B., Denzongpa, P., Grover, R. K., Sebastian, P., Saikia, T., Oswal, K., et al. (2019) · The Lancet Oncology · doi:10.1016/s1470-2045(19)30531-5 · Cited by 136 · see citing works
Self-citationCost effectiveness of strategies for cervical cancer prevention in India
Chauhan, A. S., Prinja, S., Srinivasan, R., Rai, B., Malliga, J., Jyani, G., Gupta, N., & Ghoshal, S. (2020) · PLOS ONE · doi:10.1371/journal.pone.0238291 · Cited by 75 · see citing works
“Using an individual based stochastic model for India, Diaz et al (2008) reported mean cancer reduction as 29%, 21% and 33%, when women were screened thrice per lifetime with VIA, cytology and HPV DNA, respectively.”
InfluentialBarriers to HPV vaccination among adolescent girls in India: A scoping review
Josten, K., Rose Dhar, R., Reshmi, B., Natti Krishna, V., & Vennila, J. (2026) · The Indian Journal of Medical Research · doi:10.25259/ijmr_1834_2025 · Cited by 6 · see citing works
- Authors
- Mehrotra, R., Hariprasad, R., Rajaraman, P., Mahajan, V., Grover, R., Kaur, P., & Swaminathan, S.
- Affiliations
- Indian Council of Medical Research (IN)
- Corresponding author
- Mehrotra, Ravi
- Venue
- Journal of Global Oncology
- Published
- 2018-12
- Volume
- 4
- Issue
- 4
- Pages
- 1-4
- ISSN
- 2378-9506 (ISSN-L)
- PMC
- PMC6180758
- OpenAlex
- W2752739950
- Cited by
- 25
- References
- 0
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 3 · 2023: 3 · 2022: 2 · 2021: 4 · 2020: 4 · 2019: 2 · 2018: 2
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Journal of Global Oncology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Epidemiology › Cervical Cancer and HPV Research
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Women's cancer prevention and management
- Social Sciences › Health › Vaccine Coverage and Hesitancy
- Keywords
- HPV vaccine, cervical cancer prevention, vaccine introduction, India, cervical cancer incidence, HPV vaccination program
- MeSH terms
- Uterine Cervical Neoplasms, Female, Humans, India, Primary Prevention, Immunization Programs, Papillomavirus Infections, Papillomavirus Vaccines
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
